GlaxoSmithKline
London · Founded 1929
About GlaxoSmithKline
GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people. GSK's Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, the use of genetics, and advanced technologies. The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries. The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.
Company Facts
- Founded: 1929
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 10,001+
- Estimated revenue: $10M+
- Total funding: $25.5M
- Funding stage: IPO
- Last round: Grant (Mar 2021)
- Ticker: nyse:GSK
- Website: gsk.com
- Phone: +44 20 8047 5000
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/glaxosmithkline-114217 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.